Médicaments à usage humain – Rapport public européen d’évaluation (EPAR) : Koselugo, selumetinib, Date d’autorisation : 17/06/2021, Révision : 9, Statut : Autorisé
Koselugo is a medicine used to treat plexiform neurofibromas, benign (non-cancerous) tumours along the nerves, when they cause symptoms and cannot be removed by surgery in adults a…